Breathe Technologies has received 510(k) clearance from the US Food and Drug Administration (FDA) for its critical care Life2000 ventilation system.
The Life2000 ventilation system is designed to provide continuous or intermittent support for the care of individuals who require mechanical ventilation.
Go deeper with GlobalData
Breathe Technologies president Larry Mastrovich said: “This clearance underscores our commitment to providing healthcare providers and patients with another therapeutic option for critical care ventilation.”
Suitable for use in the home and institutional settings, the ventilation system is indicated for adult patients who require positive pressure ventilation delivered invasively, through an ET tube or non-invasively, through a mask.
The ventilator was designed for administration by qualified, trained personnel under the direction of a physician.
Breathe Technologies anticipates that the Life2000 ventilation system will be commercially available in the US later in 2015.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataHeadquartered in California, US, Breathe Technologies is a developer and manufacturer of innovative medical technologies for patients with respiratory insufficiency and neuromuscular diseases.
The company also manufactures the non-invasive open ventilation (NIOV) system, the first lightweight and wearable ventilator on the market that reduces the work of breathing and supports improved patient mobility.
NIOV is approved by the FDA for use by individuals who experience shortness of breath or have difficulty breathing due to chronic obstructive pulmonary disease stages III-IV, interstitial lung disease, neuromuscular conditions, as well as pre / post lung transplant.
Image: Respiratory therapist examining a mechanically ventilated patient on an Intensive Care Unit. Photo: courtesy of Rcp.basheer.
